Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Profit After Tax: 2009-2025

Historic Profit After Tax for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $71.7 million.

  • Pediatrix Medical's Profit After Tax rose 26884.93% to $71.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.2 million, marking a year-over-year increase of 16389.36%. This contributed to the annual value of -$99.1 million for FY2024, which is 6399.98% down from last year.
  • According to the latest figures from Q3 2025, Pediatrix Medical's Profit After Tax is $71.7 million, which was up 26884.93% from $39.3 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Profit After Tax registered a high of $71.7 million during Q3 2025, and its lowest value of -$153.0 million during Q2 2024.
  • Over the past 5 years, Pediatrix Medical's median Profit After Tax value was $27.8 million (recorded in 2022), while the average stood at $9.1 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 64106.85% in 2024, then soared by 41392.81% in 2025.
  • Over the past 5 years, Pediatrix Medical's Profit After Tax (Quarter) stood at $47.5 million in 2021, then tumbled by 41.55% to $27.8 million in 2022, then crashed by 547.54% to -$124.3 million in 2023, then skyrocketed by 124.52% to $30.5 million in 2024, then soared by 135.26% to $71.7 million in 2025.
  • Its Profit After Tax was $71.7 million in Q3 2025, compared to $39.3 million in Q2 2025 and $20.7 million in Q1 2025.